The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report
Open accessAbstract
BACKGROUND: In vitro diagnostic (IVD) investigations are indispensable for routine patient management. Appropriate testing allows early-stage interventions, reducing late-stage healthcare expenditure (HCE). AIM: To investigate HCE on IVDs in two developed markets and to assess the perceived value of IVDs on clinical decision-making. Physician-perceived HCE on IVD was evaluated, as well as desired features of new diagnostic markers. METHODS: Past and current HCE on IVD was calculated for the US and Germany. A total of 79 US/German oncologists and cardiologists were interviewed to assess the number of cases where: physicians ask for IVDs; IVDs are used for initial diagnosis, treatment monitoring, or post-treatment; and decision-making is based on an IVD test result. A sample of 201 US and German oncologists and cardiologists was questioned regarding the proportion of HCE they believed to be attributable to IVD testing. After disclosing the actual IVD HCE, the physician's perception of the appropriateness of the amount was captured. Finally, the association between physician-rated impact of IVD on decision-making and perceived contribution of IVD expenditure on overall HCE was assessed. RESULTS: IVD costs account for 2.3% and 1.4% of total HCE in the US and Germany. Most physicians (81%) believed that the actual HCE on IVDs was >5%; 19% rated the spending correctly (0-4%, p<0.001). When informed of the actual amount, 64% of physicians rated this as appropriate (p<0.0001); 66% of decision-making was based on IVD. Significantly, more physicians asked for either additional clinical or combined clinical/health economic data than for the product (test/platform) alone (p<0.0001). CONCLUSIONS: Our results indicate a poor awareness of actual HCE on IVD, but a high attributable value of diagnostic procedures for patient management. New markers should deliver actionable and medically relevant information, to guide decision-making and foster improved patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A significant proportion, 66 %, of clinical decisionmaking is based on in vitro diagnostics (IVD) [15].”
From Machine learning-based clinical decision support using laboratory data (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Porter, M. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011024 · Cited by 5,084
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
Errors in clinical laboratories or errors in laboratory medicine?
Plebani, M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.123 · Cited by 734
HER2 testing in gastric cancer: a practical approach
Rüschoff, J., Hanna, W., Bilous, M., Hofmann, M., Osamura, R. Y., Penault-Llorca, F., van de Vijver, M., & Viale, G. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.198 · Cited by 595
The Landscape of Inappropriate Laboratory Testing: A 15-Year Meta-Analysis
Zhi, M., Ding, E. L., Theisen-Toupal, J., Whelan, J., & Arnaout, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078962 · Cited by 535
The detection and prevention of errors in laboratory medicine
Plebani, M. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009222 · Cited by 479
Jeremias, A., & Gibson, C. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-9-200505030-00015 · Cited by 466
Redefining Competition in Health Care
Hester, C. (2004) · Harvard business review · Cited by 384
Research works printed but not linked: 1
- Quest Diagnostics 31st Annual J. P. Morgan Healthcare Conference January 9, 2013. Available: http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-presentations.
Cited by
Access to pathology and laboratory medicine services: a crucial gap
Wilson, M. L., Fleming, K. A., Kuti, M. A., Looi, L. M., Lago, N., & Ru, K. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30458-6 · Cited by 444
A guide to aid the selection of diagnostic tests
Kosack, C. S., Page, A.-L., & Klatser, P. R. (2017) · Bulletin of the World Health Organization · doi:10.2471/blt.16.187468 · Cited by 415
Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies
Aman, R., Mahas, A., & Mahfouz, M. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00507 · Cited by 409
Point-of-care testing based on smartphone: The current state-of-the-art (2017–2018)
Liu, J., Geng, Z., Fan, Z., Liu, J., & Chen, H. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.01.068 · Cited by 335
Point-of-care testing: applications of 3D printing
Chan, H. N., Tan, M. J. A., & Wu, H. (2017) · Lab on a Chip · doi:10.1039/c7lc00397h · Cited by 168
Metadata
- Authors
- Rohr, U.-P., Binder, C., Dieterle, T., Giusti, F., Messina, C. G. M., Toerien, E., Moch, H., & Schäfer, H. H.
- Affiliations
- University Hospital Zurich (CH)
- Kantonsspital Baselland (CH)
- European Organisation for Research and Treatment of Cancer (NL)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Schäfer, Hans Hendrik
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-04
- Volume
- 11
- Issue
- 3
- Pages
- e0149856
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4778800
- OpenAlex
- W2291253625
- Cited by
- 229
- References
- 44
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 43 · 2023: 22 · 2022: 18 · 2021: 23 · 2020: 22 · 2019: 21 · 2018: 20 · 2017: 14 · 2016: 10
- FWCI
- 40.31
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-04-14)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- edoc (University of Basel) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- health care expenditure, physician perceptions, clinical decision-making, diagnostic biomarkers, cost awareness, clinical management
- MeSH terms
- Algorithms, Cardiology, Cost-Benefit Analysis, Data Collection, Diagnostic Tests, Routine, Germany, Humans, Medical Oncology, Practice Patterns, Physicians', Surveys and Questionnaires, United States, Health Care Costs, Decision Support Systems, Clinical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report. https://app.cochat.ai/papers/10.1371/journal.pone.0149856
- The paper
- Rohr, U.-P., Binder, C., Dieterle, T., Giusti, F., Messina, C. G. M., Toerien, E., Moch, H., & Schäfer, H. H. (2016). The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report. PLOS ONE. https://doi.org/10.1371/journal.pone.0149856
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.